Indocyanine Green for Central Nervous System Tumors
Clinical trial NCT02710240 · COMPLETED
Trial details
- NCT number
- NCT02710240
- Sponsor
- Abramson Cancer Center at Penn Medicine
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-06-10
- Primary completion
- 2020-02-04
- Enrollment
- 336
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.